Table 3. Summary of the adverse events.
| Adverse event | After the first laser treatment | After the second laser treatment | After the third laser treatment | |
|---|---|---|---|---|
| Erythema | 22 (100) | 20 (90.9) | 22 (100) | |
| Transient | 20 (90.9) | 20 (90.9) | 22 (100) | |
| (17/3/0)† | (12/8/0)† | (13/9/0)† | ||
| Persistent | 2 (9.1) | 0 | 0 | |
| (0/2/0)† | ||||
| Pruritus | 19 (86.4) | 16 (72.7) | 17 (77.3) | |
| Transient | 15 (68.2) | 13 (59.1) | 16 (72.7) | |
| (10/5/0)† | (9/4/0)† | (14/2/0)† | ||
| Persistent | 4 (18.2) | 3 (13.6) | 1 (4.5) | |
| (1/3/0)† | (1/2/0)† | (0/1/0)† | ||
| Petechiae | 13 (59.1) | 14 (63.6) | 13 (59.1) | |
| Transient | 10 (45.5) | 11 (50.0) | 13 (59.1) | |
| (9/1/0)† | (8/3/0)† | (10/3/0)† | ||
| Persistent | 3 (13.6) | 3 (13.6) | 0 (0) | |
| (2/1/0)† | (2/1/0)† | |||
| Pustules | 12 (54.5) | 5 (22.7) | 5 (22.7) | |
| Transient | 7 (31.8) | 4 (18.2) | 3 (13.6) | |
| (5/2/0)† | (4/0/0)† | (2/1/0)† | ||
| Persistent | 5 (22.8) | 1 (4.5) | 2 (9.1) | |
| (4/1/0)† | (1/0/0)† | (0/2/0)† | ||
| Papules | 0 (0%) | 1 (4.5) | 0 (0) | |
| Transient | 0 | 1 (4.5) | 0 | |
| (1/0/0)† | ||||
| Persistent | 0 | 0 | 0 | |
Transient adverse events resolved in 1 to 3 days; persistent adverse event persisted for >3 days. Values are presented as number (%) or number only. †Indicates (mild/moderate/severe case number).